Concepedia

Author

Julie A. Vendrell

InsermORCID

Also Known As

J A Vendrell, J Vendrell, J. Vendrell, J.A. Vendrell, Julie A Vendrell, Julie A. Vendrell, Julie Adèle Vendrell, Julie Vendrell, Julie A. Vendrell, Vendrell, J.

95

Publications

2.5K

Citations

25

H-Index

54

Concepts

All Affiliations

InsermUniversité de MontpellierCentre National de la Recherche ScientifiqueUniversité Claude Bernard Lyon 1Centre de Recherche en Cancérologie de Lyon
JA

About

Julie A. Vendrell is an author at Inserm specializing in medicine, cancer research, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

1.1K

2

Cell Biology

7

7

1K

3

Engineering

2

2

234

4

Health Sciences

1

1

45

5

Biostatistics

1

1

224

Julie A. Vendrell

×

36

Publications

2K

Citations

22

H-Index

YearCitations

p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer

Virginie Marcel, Sandra E. Ghayad, Stéphane Belin,

Cancer Cell

2013

347

Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach

Sengül Tozlu, Igor Girault, Sophie Vacher,

Endocrine Related Cancer

2006

224

Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways

Sandra E. Ghayad, Julie A. Vendrell, Sabrina Ben Larbi,

International Journal of Cancer

2009

131

ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion

Julie A. Vendrell, Aurélie Thollet, Nhan Trung Nguyen,

Cancer Research

2012

129

Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches

Julie A. Vendrell, Sylvie Taviaux, Benoît Béganton,

Scientific Reports

2017

101

Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications

Mélanie Nugoli, Paul Chuchana, Julie A. Vendrell,

BMC Cancer

2003

99

A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells

Julie A. Vendrell, Sandra E. Ghayad, S Ben-Larbi,

Oncogene

2007

92

MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer

Paul Vilquin, Caterina F. Donini, Marie Villedieu,

Breast Cancer Research

2015

79

mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene‐expression levels

Sandra E. Ghayad, Ivan Bièche, Julie A. Vendrell,

Cancer Science

2008

76

Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer

Sandra E. Ghayad, Julie A. Vendrell, Ivan Bièche,

Journal of Molecular Endocrinology

2008

69

Page 1